High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice

J Huard1, S Verreault, R Roy

  • 1Centre de recherche en Neurobiologie, Hôpital de l'Enfant-Jésus, Québec, Canada.

Insights

Transplanted human myoblasts effectively regenerate muscle fibers in SCID mice, expressing human dystrophin. This demonstrates the potential of human myoblast transplantation for muscle regeneration therapies.

Area of Science:

  • Muscle regeneration
  • Cell transplantation
  • Immunology

Background:

  • Host myoblasts can impede muscle regeneration.
  • SCID mice lack functional T-cells, minimizing immune rejection.
  • Notexin is used to induce muscle fiber damage and initiate regeneration.

Purpose of the Study:

  • To assess the efficacy of human myoblast transplantation in muscle regeneration.
  • To investigate the survival and differentiation of transplanted human myoblasts.
  • To evaluate the role of immune response in myoblast transplantation success.

Main Methods:

  • SCID mice tibialis anterior muscles were irradiated and injected with notexin.
  • Human myoblasts were injected into the damaged muscles.
  • Muscle regeneration and human cell integration were analyzed after 1 month.

Main Results:

  • Injected human myoblasts contributed to muscle regeneration, with >90% of new fibers containing human dystrophin.
  • Human myoblasts formed functional, innervated muscle fibers and potentially satellite cells.
  • Transplantation in nude mice showed significantly lower integration (<4%), highlighting the importance of immune response.

Conclusions:

  • Transplanted human myoblasts can effectively participate in muscle regeneration in an immune-deficient environment.
  • Human myoblasts demonstrate high efficacy in regenerating muscle fibers, forming functional and innervated tissues.
  • The absence of immune rejection is crucial for successful human myoblast transplantation and muscle repair.

Related Concept Videos